Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Escalon Medical Corp. (ESMC)
USD0.18
-0.02 (-7.89%)
US OTC Healthcare Medical - Devices
Address
435 Devon Park Drive 19087
Wayne, PA, US
Wayne, PA, US
CEO
Richard J. DePiano Jr.
Website
escalonmedical.com
IPO
1992-09-11
CIK 862668 ISIN US2960743050
Description
Escalon Medical Corp. specializes in the field of ophthalmology, engaging in the development, manufacturing, promotion, and distribution of both medical devices and pharmaceutical products. Its operations span the United States and international markets. The company's product line includes a variety of diagnostic instruments for eye care. For instance, the A-Scan is designed to provide insights into the internal anatomy of the eye, while the B-Scan assists physicians in diagnosing conditions where the eye's internal media is obscured or cloudy. They also offer the UBM, a high-frequency, high-resolution ultrasound device that delivers detailed imaging of the anterior segment of the eye, alongside the Pachymeter, which accurately measures corneal thickness. Beyond diagnostic tools, Escalon supplies intraocular gas products such as C3F8 and SF6, vital for vitreoretinal surgeons who utilize them as a temporary support during detached retina surgeries. To complement this, the firm produces and distributes a patented disposable universal gas kit, ensuring the efficient delivery of these gases from the canister to the patient. Furthermore, Escalon provides disposable surgical packs tailored for vitreoretinal procedures and offers the AXIS Image management system. This web-based platform enables the seamless organization and viewing of medical images from diverse devices, manufacturers, and locations. Escalon Medical Corp. distributes its products to medical institutions through a combination of independent sales representatives, an extensive network of distributors, and its dedicated internal sales personnel. Established in 1987, the company maintains its corporate headquarters in Wayne, Pennsylvania.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.18
-0.02 (-7.89%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
16.8K
Beta
0.15
Float Shares
7.27M
Free Float %
98.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +9.62% | +67.65% | +67.65% | +65.51% | +67.65% | +69.74% | -13.64% | +203.19% | +1.79% | -64.38% | -99.66% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.18
DCF (Unlevered)
48.66
+27,707.7%
DCF (Levered)
20.43
+11,576.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
0.88
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
A+
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+0.5% Q1'26: -24.9% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+108.4% ★ Q1'26: +774.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-186.4% Q1'26: +10,771.9% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+1.1% Q1'26: -16.1% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%— Q1'26: +0.1% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+92.2% Q1'26: +2.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×3.15× ★ Q1'26: -523.60× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-14 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
10.08B
OE per share TTM
1,374.73
Owner's Yield
476,919.43%
Maintenance CapEx ratio
139.51%
Maint CapEx / Avg PPE
383.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
11
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) GRT Capital Partners, L.L.C. | 687.0K | 9.10% | 687.0K | — | 687.0K | — | IA, OO | Delaware | 2016-11-30 | ↗ |
| 2 | Allen & Company Incorporated | 635.8K | 5.70% | 635.8K | — | 635.8K | — | BD, CO | New York | 1997-02-14 | ↗ |
| 3 | Abigail P. Johnson | 585.1K | 9.99% | — | — | 585.1K | — | IN | United States of America | 2005-02-14 | ↗ |
| 4 | FMR Corp. | 585.1K | 9.99% | — | — | 585.1K | — | HC | Delaware | 2005-02-14 | ↗ |
| 5 | (1) GRT Deep Woods GP, L.L.C. | 470.9K | 6.24% | 470.9K | — | 470.9K | — | OO | Delaware | 2016-11-30 | ↗ |
| 6 | (1) GRT Deep Woods Partners, L.P. | 470.9K | 6.24% | 470.9K | — | 470.9K | — | PN | Delaware | 2016-11-30 | ↗ |
| 7 | (1) SKK Deep Woods GP, LLC | 310.2K | 4.11% | 310.2K | — | 310.2K | — | OO | Delaware | 2018-02-13 | ↗ |
| 8 | (1) SKK Deep Woods Partners, LP | 310.2K | 4.11% | 310.2K | — | 310.2K | — | PN | Delaware | 2018-02-13 | ↗ |
| 9 | (1) Shepherd Kaplan Krochuk, LLC | 310.2K | 4.11% | 310.2K | — | 310.2K | — | IA, OO | Delaware | 2018-02-13 | ↗ |
| 10 | Edward C. Johnson 3d | 20.1K | 0.31% | — | — | 20.1K | — | IN | United States of America | 2007-12-10 | ↗ |
| 11 | Allen Holding Inc. | — | 5.70% | — | — | — | — | HC | Delaware | 1997-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
2.00M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+2,000,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-02-14 | DEPIANO RICHARD J | Director / 10% Owner | J-Other | A | Series A convertible preferred stock | 1,534,884 | 0.00 | — | 1,534,884 | — | ↗ |
| 2017-02-13 | Jacovini David James | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-02-13 | Dogum John | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-05-12 | Trusk C Todd | Director | A-Award | A | Director stock option (right to buy) | 7,000 | 0.79 | 5.5K | 7,250 | — | ↗ |
| 2016-05-12 | NAPOLITANO LISA A | Director | A-Award | A | Director stock option (right to buy) | 2,000 | 0.79 | 1.6K | 46,000 | — | ↗ |
| 2016-05-12 | DEPIANO RICHARD J | Director | A-Award | A | Director stock option (right to buy) | 10,000 | 0.79 | 7.9K | 471,175 | — | ↗ |
| 2016-05-12 | Closkey C Sean | Director | A-Award | A | Director stock option (right to buy) | 2,000 | 0.79 | 1.6K | 9,000 | — | ↗ |
| 2015-11-13 | Trusk C Todd | Director | — | D | Common Stock | 0 | 0.00 | — | 250 | — | ↗ |
| 2014-05-08 | Wallace Mark | Officer | A-Award | A | Stock option (right to buy) | 35,000 | 1.57 | 55.0K | 92,467 | — | ↗ |
| 2014-05-08 | O'Connor Robert Michael | Officer | A-Award | A | Stock Option (right to buy stock) | 35,000 | 1.57 | 55.0K | 149,000 | — | ↗ |
| 2014-05-08 | NAPOLITANO LISA A | Director | A-Award | A | Director Stock option (right to buy) | 2,000 | 1.57 | 3.1K | 44,000 | — | ↗ |
| 2014-05-08 | DePiano Richard J Jr | Director / Officer | A-Award | A | Common Stock | 45,000 | 1.57 | 70.7K | 172,706 | — | ↗ |
| 2014-05-08 | DEPIANO RICHARD J | Director | A-Award | A | Common Stock | 10,000 | 1.57 | 15.7K | 461,175 | — | ↗ |
| 2014-05-08 | Closkey C Sean | Director | A-Award | A | Director Stock Option (right to buy) | 5,000 | 1.57 | 7.9K | 5,000 | — | ↗ |
| 2014-05-08 | CHOATE FRED G | Director | A-Award | A | Director Stock OPtion (right to Buy) | 2,000 | 1.57 | 3.1K | 32,000 | — | ↗ |
| 2013-05-17 | Closkey C Sean | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-12-17 | DePiano Richard J Jr | Officer | D-Return | A | Common Stock | 500 | 1.08 | 538.00 | 127,706 | — | ↗ |
| 2009-11-16 | Wallace Mark | Officer | A-Award | A | Stock Option (right to buy) | 10,000 | 1.51 | 15.1K | 57,467 | — | ↗ |
| 2009-11-16 | O'Connor Robert Michael | Officer | A-Award | A | Stock Option (right to buy) | 14,000 | 1.51 | 21.1K | 114,000 | — | ↗ |
| 2009-11-16 | DePiano Richard J Jr | Officer | A-Award | A | Stock Option (right to buy) | 12,000 | 1.51 | 18.1K | 112,573 | — | ↗ |
| 2009-11-16 | DEPIANO RICHARD J | Director / Officer | A-Award | A | Stock Option (right to buy) | 20,000 | 1.51 | 30.2K | 451,175 | — | ↗ |
| 2008-09-25 | Wallace Mark | Officer | A-Award | A | Stock Option (right to buy) | 20,000 | 2.22 | 44.4K | 47,467 | — | ↗ |
| 2008-09-25 | O'Connor Robert Michael | Officer | A-Award | A | Stock Option (right to buy) | 20,000 | 2.22 | 44.4K | 100,000 | — | ↗ |
| 2008-09-25 | NAPOLITANO LISA A | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 2.22 | 22.2K | 42,000 | — | ↗ |
| 2008-09-25 | KWAN WILLIAM L G | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 2.22 | 22.2K | 80,000 | — | ↗ |
| 2008-09-25 | FEDERMAN JAY L MD | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 2.22 | 22.2K | 77,072 | — | ↗ |
| 2008-09-25 | DePiano Richard J Jr | Officer | A-Award | A | Stock Option (right to buy) | 20,000 | 2.22 | 44.4K | 100,573 | — | ↗ |
| 2008-09-25 | DEPIANO RICHARD J | Director / Officer | A-Award | A | Stock Option (right to buy) | 25,000 | 2.22 | 55.5K | 431,175 | — | ↗ |
| 2008-09-25 | COPPOLA ANTHONY J | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 2.22 | 22.2K | 45,000 | — | ↗ |
| 2008-09-25 | CHOATE FRED G | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 2.22 | 22.2K | 30,000 | — | ↗ |
| 2007-12-21 | Wallace Mark | Officer | — | D | Stock Option | 5,000 | 3.13 | 15.7K | 0 | — | ↗ |
| 2007-11-29 | O'Connor Robert Michael | Officer | A-Award | A | Stock Option (right to buy) | 20,000 | 3.09 | 61.8K | 80,000 | — | ↗ |
| 2007-11-29 | NAPOLITANO LISA A | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 3.09 | 30.9K | 32,000 | — | ↗ |
| 2007-11-29 | KWAN WILLIAM L G | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 3.09 | 30.9K | 70,000 | — | ↗ |
| 2007-11-29 | FEDERMAN JAY L MD | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 3.09 | 30.9K | 67,072 | — | ↗ |
| 2007-11-29 | DePiano Richard J Jr | Officer | A-Award | A | Stock Option (right to buy) | 20,000 | 3.09 | 61.8K | 80,573 | — | ↗ |
| 2007-11-29 | DEPIANO RICHARD J | Director / Officer | A-Award | A | Stock Option (right to buy) | 25,000 | 3.09 | 77.3K | 406,175 | — | ↗ |
| 2007-11-29 | COPPOLA ANTHONY J | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 3.09 | 30.9K | 35,000 | — | ↗ |
| 2007-11-29 | CHOATE FRED G | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 3.09 | 30.9K | 20,000 | — | ↗ |
| 2006-12-28 | DePiano Richard J Jr | Officer | — | D | Common Stock | 0 | 0.00 | — | 206 | — | ↗ |
| 2006-11-08 | KWAN WILLIAM L G | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 2.65 | 26.5K | 60,000 | — | ↗ |
| 2006-06-30 | Wallace Mark | Officer | — | D | Stock Option | 5,000 | 6.19 | 30.9K | 0 | — | ↗ |
| 2006-06-30 | O'Connor Robert Michael | Officer | — | D | Stock Option (right to buy) | 60,000 | 5.05 | 303.0K | 0 | — | ↗ |
| 2006-06-30 | DePiano Richard J Jr | Officer | — | D | Stock Option | 700 | 2.38 | 1.7K | 0 | — | ↗ |
| 2006-03-03 | David Berkowitz | Officer | — | D | Stock Option (right to buy) | 18,000 | 4.82 | 86.8K | 0 | — | ↗ |
| 2005-10-27 | CHOATE FRED G | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 5.59 | 55.9K | 10,816 | — | ↗ |
| 2005-10-11 | DEPIANO RICHARD J | Director / Officer | M-Exempt | A | Common Stock | 112,500 | 2.25 | 253.1K | 144,278 | — | ↗ |
| 2005-08-17 | RIMMER HENRY M | Officer | A-Award | A | Director Stock Option (right to buy) | 20,000 | 8.06 | 161.2K | 123,000 | — | ↗ |
| 2005-08-17 | NAPOLITANO LISA A | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 8.06 | 80.6K | 0 | — | ↗ |
| 2005-08-17 | KWAN WILLIAM L G | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 8.06 | 80.6K | 0 | — | ↗ |
| 2005-08-17 | FEDERMAN JAY L MD | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 8.06 | 80.6K | 0 | — | ↗ |
| 2005-08-17 | DEPIANO RICHARD J | Director / Officer | A-Award | A | Director Stock Option (right to buy) | 40,000 | 8.06 | 322.4K | 324,397 | — | ↗ |
| 2005-08-17 | COPPOLA ANTHONY J | Director | A-Award | A | Director Stock Option (right to buy) | 10,000 | 8.06 | 80.6K | 0 | — | ↗ |
| 2005-07-18 | Karsch Mark H | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-12-06 | ODONNELL JEFFREY F | Director | S-Sale | D | Common Stock | 10,000 | 9.42 | 94.2K | 0 | — | ↗ |
| 2004-03-04 | ODONNELL JEFFREY F | Director | M-Exempt | A | Common Stock | 5,000 | 2.13 | 10.6K | 0 | — | ↗ |
| 2004-03-04 | NAPOLITANO LISA A | Director | M-Exempt | A | Common Stock | 8,000 | 6.94 | 55.5K | 0 | — | ↗ |
| 2004-03-04 | DEPIANO RICHARD J | Director / Officer | S-Sale | D | Common Stock | 16,000 | 17.46 | 279.4K | 31,778 | — | ↗ |
| 2004-03-04 | COPPOLA ANTHONY J | Director | S-Sale | D | Common Stock | 10,000 | 16.54 | 165.4K | 0 | — | ↗ |
| 2004-03-03 | KWAN WILLIAM L G | Director | M-Exempt | A | Common Stock | 10,000 | 6.94 | 69.4K | 0 | — | ↗ |
| 2004-03-03 | FEDERMAN JAY L MD | Director | S-Sale | D | Common Stock | 5,000 | 16.63 | 83.2K | 22,072 | — | ↗ |
| 2004-03-03 | DEPIANO RICHARD J | Director / Officer | M-Exempt | D | Employer Stock Option (right to buy) | 9,980 | 2.06 | 20.6K | 31,778 | — | ↗ |
| 2004-03-01 | RIMMER HENRY M | Officer | S-Sale | D | Common Stock | 23,000 | 13.51 | 310.7K | 3,000 | — | ↗ |
| 2004-03-01 | DEPIANO RICHARD J | Director / Officer | M-Exempt | D | Employer Stock Option (right to buy) | 9,980 | 1.56 | 15.6K | 31,778 | — | ↗ |
| 2004-02-27 | FEDERMAN JAY L MD | Director | M-Exempt | D | Common Stock | 10,000 | 2.06 | 20.6K | 22,072 | — | ↗ |
| 2004-02-26 | FEDERMAN JAY L MD | Director | S-Sale | D | Common Stock | 20,000 | 10.17 | 203.4K | 22,072 | — | ↗ |
| 2004-02-26 | DEPIANO RICHARD J | Director / Officer | S-Sale | D | Common Stock | 10,800 | 10.17 | 109.8K | 31,778 | — | ↗ |
| 2004-02-25 | ODONNELL JEFFREY F | Director | M-Exempt | D | Director Stock Option (right to buy) | 4,400 | 2.13 | 9.4K | 0 | — | ↗ |
| 2004-02-25 | KWAN WILLIAM L G | Director | M-Exempt | A | Common Stock | 4,400 | 2.06 | 9.1K | 0 | — | ↗ |
| 2004-02-25 | DEPIANO RICHARD J | Director / Officer | S-Sale | D | Common Stock | 7,000 | 10.14 | 71.0K | 31,778 | — | ↗ |
| 2004-02-25 | COPPOLA ANTHONY J | Director | S-Sale | D | Common Stock | 4,000 | 10.14 | 40.6K | 0 | — | ↗ |
| 2004-02-23 | ODONNELL JEFFREY F | Director | M-Exempt | A | Common Stock | 3,400 | 1.45 | 4.9K | 0 | — | ↗ |
| 2004-02-23 | KWAN WILLIAM L G | Director | M-Exempt | D | Director Stock Option (right to buy) | 5,600 | 2.06 | 11.6K | 0 | — | ↗ |
| 2004-02-23 | DEPIANO RICHARD J | Director / Officer | M-Exempt | D | Employer Stock Option (right to buy) | 8,197 | 1.45 | 11.9K | 31,778 | — | ↗ |
| 2004-02-23 | COPPOLA ANTHONY J | Director | M-Exempt | D | Director Stock Option (right to buy) | 6,000 | 1.45 | 8.7K | 0 | — | ↗ |
| 2004-02-20 | ODONNELL JEFFREY F | Director | S-Sale | D | Common Stock | 4,500 | 10.14 | 45.6K | 0 | — | ↗ |
| 2004-02-20 | KWAN WILLIAM L G | Director | M-Exempt | D | Director Stock Option (right to buy) | 4,500 | 1.45 | 6.5K | 0 | — | ↗ |
| 2004-02-20 | DEPIANO RICHARD J | Director / Officer | M-Exempt | D | Employer Stock Option (right to buy) | 15,000 | 1.45 | 21.8K | 31,778 | — | ↗ |
| 2004-02-20 | COPPOLA ANTHONY J | Director | M-Exempt | A | Common Stock | 4,000 | 1.45 | 5.8K | 0 | — | ↗ |
| 2004-02-18 | ODONNELL JEFFREY F | Director | S-Sale | D | Common Stock | 2,100 | 10.33 | 21.7K | 0 | — | ↗ |
| 2004-02-18 | KWAN WILLIAM L G | Director | M-Exempt | D | Director Stock Option (right to buy) | 2,100 | 1.45 | 3.0K | 0 | — | ↗ |
| 2004-02-18 | DEPIANO RICHARD J | Director / Officer | M-Exempt | D | Employer Stock Option (right to buy) | 7,200 | 1.45 | 10.4K | 31,778 | — | ↗ |
| 2003-12-19 | RIMMER HENRY M | Officer | M-Exempt | A | Common Stock | 2,333 | 1.56 | 3.6K | 3,000 | — | ↗ |
| 2003-12-19 | DEPIANO RICHARD J | Director / Officer | M-Exempt | A | Common Stock | 19,603 | 1.45 | 28.4K | 31,778 | — | ↗ |
| 2003-12-03 | RIMMER HENRY M | Officer | M-Exempt | D | Employer Stock Option (right to buy) | 2,000 | 1.45 | 2.9K | 0 | — | ↗ |
| 2003-11-24 | RIMMER HENRY M | Officer | S-Sale | D | Common Stock | 2,000 | 6.80 | 13.6K | 0 | — | ↗ |
| 2003-11-18 | RIMMER HENRY M | Officer | M-Exempt | A | Common Stock | 2,000 | 1.45 | 2.9K | 0 | — | ↗ |
| 2003-11-11 | RIMMER HENRY M | Officer | A-Award | A | Common Stock | 10,000 | 6.94 | 69.4K | 69,667 | — | ↗ |
| 2003-11-11 | ODONNELL JEFFREY F | Director | A-Award | A | Common Stock | 10,000 | 6.94 | 69.4K | 56,000 | — | ↗ |
| 2003-11-11 | NAPOLITANO LISA A | Director | A-Award | A | Common Stock | 10,000 | 6.94 | 69.4K | 10,000 | — | ↗ |
| 2003-11-11 | KWAN WILLIAM L G | Director | A-Award | A | Common Stock | 10,000 | 6.94 | 69.4K | 70,000 | — | ↗ |
| 2003-11-11 | DEPIANO RICHARD J | Director / Officer | A-Award | A | Common Stock | 25,000 | 6.94 | 173.5K | 519,861 | — | ↗ |
| 2003-11-11 | COPPOLA ANTHONY J | Director | A-Award | A | Common Stock | 10,000 | 6.94 | 69.4K | 40,000 | — | ↗ |
| 2003-08-15 | NAPOLITANO LISA A | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
3.2K
Shares Outstanding
7.42M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2016 | Richard J. DePiano, Jr. Chief Executive Officer | 182.0K | — | — | 18.7K | — | 12.2K | 212.9K | 8.78% | ↗ |
| 2 | 2016 | Robert M. O’Connor Chief Financial Officer | 181.0K | — | — | 14.5K | — | 11.9K | 207.5K | 7.01% | ↗ |
| 3 | 2016 | Mark Wallace Chief Operating Officer | 154.0K | — | — | 14.5K | — | 810.00 | 169.3K | 8.58% | ↗ |
| 4 | 2016 | Richard J. DePiano Chairman | 31.0K | — | — | 6.0K | — | 112.0K | 149.0K | 4.05% | ↗ |
| 5 | 2015 | Richard J. DePiano, Jr. Chief Executive Officer | 215.0K | — | — | 18.7K | — | 11.3K | 245.0K | 7.63% | ↗ |
| 6 | 2015 | Robert M. O’Connor Chief Financial Officer | 212.6K | — | — | 14.5K | — | 10.8K | 238.0K | 6.11% | ↗ |
| 7 | 2015 | Mark Wallace Chief Operating Officer | 175.0K | — | — | 14.5K | — | 810.00 | 190.3K | 7.64% | ↗ |
| 8 | 2015 | Richard J. DePiano Chairman | 50.0K | — | — | 15.3K | — | 110.4K | 175.7K | 8.69% | ↗ |
| 9 | 2014 | Richard J. DePiano, Jr. Chief Executive Officer, President and General Counsel | 215.0K | — | — | 37.4K | — | 11.3K | 263.7K | 14.18% | ↗ |
| 10 | 2014 | Richard J. DePiano, Jr. Chief Executive Officer | 215.0K | — | — | 37.4K | — | 11.3K | 263.7K | 14.18% | ↗ |
| 11 | 2014 | Robert M. O’Connor Chief Financial Officer | 212.6K | — | — | 29.1K | — | 10.8K | 252.5K | 11.51% | ↗ |
| 12 | 2014 | Robert M. O’Connor Chief Financial Officer | 212.6K | — | — | 29.1K | — | 10.8K | 252.5K | 11.51% | ↗ |
| 13 | 2014 | Mark Wallace Chief Operating Officer | 175.0K | — | — | 29.1K | — | 810.00 | 204.9K | 14.19% | ↗ |
| 14 | 2014 | Mark Wallace Chief Operating Officer | 175.0K | — | — | 29.1K | — | 810.00 | 204.9K | 14.19% | ↗ |
| 15 | 2014 | Richard J. DePiano Chairman | 50.0K | — | — | 8.3K | — | 4.8K | 63.1K | 13.16% | ↗ |
| 16 | 2014 | Richard J. DePiano Chairman | 50.0K | — | — | 8.3K | — | 4.8K | 63.1K | 13.16% | ↗ |
| 17 | 2013 | Richard J. DePiano Chairman | 256.6K | — | — | — | — | 4.8K | 261.4K | 0.00% | ↗ |
| 18 | 2013 | Richard J. DePiano, Jr. Chief Executive Officer and General Counsel | 215.0K | — | — | — | — | 9.6K | 224.6K | 0.00% | ↗ |
| 19 | 2013 | Richard J. DePiano, Jr. Chief Executive Officer, President and General Counsel | 215.0K | — | — | — | — | 9.6K | 224.6K | 0.00% | ↗ |
| 20 | 2013 | Robert M. O’Connor Chief Financial Officer | 212.6K | — | — | — | — | 9.6K | 222.2K | 0.00% | ↗ |
| 21 | 2013 | Mark G. Wallace Chief Operating Officer | 175.0K | — | — | — | — | — | 175.0K | 0.00% | ↗ |
| 22 | 2013 | Mark Wallace Chief Operating Officer | 175.0K | — | — | — | — | — | 175.0K | 0.00% | ↗ |
| 23 | 2012 | Richard J. DePiano Chairman and Chief Executive Officer | 348.1K | — | — | — | — | 17.9K | 366.0K | 0.00% | ↗ |
| 24 | 2012 | Richard J. DePiano Chairman | 348.1K | — | — | — | — | 17.9K | 366.0K | 0.00% | ↗ |
| 25 | 2012 | Richard J. DePiano, Jr. Chief Executive Officer, President and General Counsel | 215.0K | — | — | — | — | 9.6K | 224.6K | 0.00% | ↗ |
| 26 | 2012 | Richard J. DePiano, Jr. Chief Executive Officer and General Counsel | 215.0K | — | — | — | — | 9.6K | 224.6K | 0.00% | ↗ |
| 27 | 2012 | Richard J. DePiano, Jr. President and General Counsel | 215.0K | — | — | — | — | 9.6K | 224.6K | 0.00% | ↗ |
| 28 | 2012 | Robert M. O’Connor Chief Financial Officer | 212.6K | — | — | — | — | 9.6K | 222.2K | 0.00% | ↗ |
| 29 | 2012 | Mark G. Wallace Chief Operating Officer | 175.0K | — | — | — | — | — | 175.0K | 0.00% | ↗ |
| 30 | 2012 | Mark Wallace Chief Operating Officer | 175.0K | — | — | — | — | — | 175.0K | 0.00% | ↗ |
| 31 | 2011 | Richard J. DePiano Chairman and Chief Executive Officer | 394.4K | — | — | 14.0K | — | 17.0K | 425.4K | 3.28% | ↗ |
| 32 | 2011 | Richard J. DePiano Chairman | 394.4K | — | — | — | — | 17.0K | 411.4K | 0.00% | ↗ |
| 33 | 2011 | Richard J. DePiano, Jr. President and General Counsel | 240.5K | — | — | 28.0K | — | 9.6K | 278.1K | 10.07% | ↗ |
| 34 | 2011 | Richard J. DePiano, Jr. Chief Executive Officer and General Counsel | 240.5K | — | — | — | — | 9.6K | 250.1K | 0.00% | ↗ |
| 35 | 2011 | Robert M. O’Connor Chief Financial Officer | 234.5K | — | — | — | — | 9.6K | 244.1K | 0.00% | ↗ |
| 36 | 2011 | Mark G. Wallace Chief Operating Officer | 198.6K | — | — | — | — | — | 198.6K | 0.00% | ↗ |
| 37 | 2010 | Richard J. DePiano Chairman and Chief Executive Officer | 313.3K | — | — | 38.6K | — | 22.2K | 374.1K | 10.31% | ↗ |
| 38 | 2010 | Robert M. O’Connor Chief Financial Officer | 191.3K | — | — | 19.2K | — | 9.6K | 220.2K | 8.74% | ↗ |
| 39 | 2010 | Richard J. DePiano, Jr. President and General Counsel | 167.7K | — | — | 27.3K | — | 9.6K | 204.6K | 13.35% | ↗ |
| 40 | 2010 | Mark G. Wallace Chief Operating Officer | 147.2K | — | — | 11.3K | — | — | 158.4K | 7.11% | ↗ |
| 41 | 2009 | Richard J. DePiano Chairman and Chief Executive Officer | 349.3K | — | — | — | — | — | 421.2K | 0.00% | ↗ |
| 42 | 2009 | Richard J. DePiano Chairman and Chief Executive Officer | 349.3K | — | — | 51.9K | — | 20.0K | 421.2K | 12.31% | ↗ |
| 43 | 2009 | Robert M. O’Connor Chief Financial Officer | 217.1K | — | — | — | — | — | 243.3K | 0.00% | ↗ |
| 44 | 2009 | Robert M. O’Connor Chief Financial Officer | 217.1K | — | — | 16.6K | — | 9.6K | 243.3K | 6.82% | ↗ |
| 45 | 2009 | Richard J. DePiano, Jr. President and General Counsel | 191.4K | — | — | 16.6K | — | 9.6K | 217.6K | 7.63% | ↗ |
| 46 | 2009 | Richard J. DePiano, Jr. President and General Counsel | 191.4K | — | — | — | — | — | 217.6K | 0.00% | ↗ |
| 47 | 2009 | Mark G. Wallace Chief Operating Officer | 161.0K | — | — | 4.4K | — | — | 165.4K | 2.68% | ↗ |
| 48 | 2009 | Mark Wallace Chief Operating Officer | 161.0K | — | — | — | — | — | 165.4K | 0.00% | ↗ |
| 49 | 2008 | Richard J. DePiano Chairman and Chief | 336.3K | — | — | — | — | — | 413.8K | 0.00% | ↗ |
| 50 | 2008 | Richard J. DePiano Chairman and Chief Executive Officer | 336.3K | — | — | — | — | — | 403.6K | 0.00% | ↗ |
| 51 | 2008 | Robert M. O’Connor Chief Financial Officer | 205.4K | — | — | — | — | — | 223.5K | 0.00% | ↗ |
| 52 | 2008 | Richard J. DePiano, Jr. President and General Counsel | 180.0K | — | — | — | — | — | 208.0K | 0.00% | ↗ |
| 53 | 2008 | Mark Wallace Chief Operating Officer | 93.2K | 60.0K | — | — | — | — | 156.1K | 0.00% | ↗ |
| 54 | 2008 | Mark Wallace Chief Operating Officer | 93.2K | 60.0K | — | — | — | — | 156.1K | 0.00% | ↗ |
| 55 | 2007 | Richard J. DePiano Chairman and Chief | 317.7K | 250.0K | — | — | — | — | 600.5K | 0.00% | ↗ |
| 56 | 2007 | Richard J. DePiano Chairman and Chief Executive Officer | 317.7K | 250.0K | — | — | — | — | 600.5K | 0.00% | ↗ |
| 57 | 2007 | Richard J. DePiano, Jr. Chief Executive Officer, President and General Counsel | 317.7K | 250.0K | — | — | — | — | 590.9K | 0.00% | ↗ |
| 58 | 2007 | Robert M. O’Connor Chief Financial Officer | 200.0K | 25.0K | — | — | — | — | 225.0K | 0.00% | ↗ |
| 59 | 2007 | Robert M. O’Connor Chief Financial Officer | 200.0K | 25.0K | — | — | — | — | 225.0K | 0.00% | ↗ |
| 60 | 2007 | Richard J. DePiano, Jr. President and General Counsel | 127.2K | 80.0K | — | — | — | — | 214.6K | 0.00% | ↗ |
| 61 | 2007 | Richard J. DePiano, Jr. | 127.2K | 80.0K | — | — | — | — | 214.6K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Richard J. DePiano Jr. | President, Chief Executive Officer, General Counsel & Chairman of Board | 205.0K | male |
| Mark G. Wallace | Chief Operating Officer and Principal Financial & Accounting Officer | 162.0K | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ESMC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
